Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank 33rd meeting of the Committee for Orphan Medicinal Products 24 March 2003Press releaseHumanRare diseases European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 19 March 2003 20 March 2003Press release Committee for veterinary medicinal products: Meeting of 11 to 13 March 2003 14 March 2003Press releaseVeterinary European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 20 February 2003 24 February 2003Press release EMEA Management Board elects new chairman and sets out proposed work programme for 2004 21 February 2003Press releaseCorporate Committee for veterinary medicinal products: Meeting of 11 to 13 February 2003 14 February 2003Press releaseVeterinary 32nd meeting of the Committee for Orphan Medicinal Products 11 February 2003Press releaseHumanRare diseases European Agency for the Evaluation of Medicinal Products: EudraLink Launch meeting 28-29 January 2003 5 February 2003Press release Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept) 5 February 2003News European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 21 to 23 January 2003 23 January 2003Press release 1 … 351 352 353 354 355 Page 355 of 384 356 357 358 359 … 384
33rd meeting of the Committee for Orphan Medicinal Products 24 March 2003Press releaseHumanRare diseases
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 19 March 2003 20 March 2003Press release
Committee for veterinary medicinal products: Meeting of 11 to 13 March 2003 14 March 2003Press releaseVeterinary
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 20 February 2003 24 February 2003Press release
EMEA Management Board elects new chairman and sets out proposed work programme for 2004 21 February 2003Press releaseCorporate
Committee for veterinary medicinal products: Meeting of 11 to 13 February 2003 14 February 2003Press releaseVeterinary
32nd meeting of the Committee for Orphan Medicinal Products 11 February 2003Press releaseHumanRare diseases
European Agency for the Evaluation of Medicinal Products: EudraLink Launch meeting 28-29 January 2003 5 February 2003Press release
Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept) 5 February 2003News
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 21 to 23 January 2003 23 January 2003Press release